S. 4152 · 117th Congress

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Stage
In committee
Sponsor
Mark Kelly
Introduced
2022-05-05
Latest action
2022-05-05 · Introduced in Senate

Action history

  1. 2022-05-05Introduced in Senate
  2. 2022-05-05Read twice and referred to the Committee on Health, Education, Labor, and Pensions.